Since the first description of The one step PCR, performed as described previously,'0 produced a weak and inconsistent PCR product, and we therefore introduced a two step amplification procedure (fig 1) . Using this nested PCR assay, HHV8 DNA was detected in all skin biopsy specimens with Kaposi sarcoma. No HHV8 DNA was found in the four biopsy specimens of HIV positive patients without clinical evidence of Kaposi sarcoma. HHV8 DNA was not detected in the 10 biopsy specimens of HIV negative patients with various mesenchymal skin tumours or unspecific inflammatory skin lesions (table 2) . These biopsy specimens all gave a positive result for human ,-globin, confirming adequate preservation and extraction of the DNA tested. Furthermore, amplification did not occur when cytomegalovirus infected fibroblasts or Epstein-Barr virus transformed lymphoid cell lines were used as a DNA template (data not shown). 100% of HIV associated and in 87-100% of classic Kaposi sarcomas.'0 13 15 These values were obtained mainly from unfixed, native tissue. We were able to improve the sensitivity and to extend the applicability to formalin fixed material by introducing a nested PCR assay. Using adequate controls, the presence of HHV8 DNA was restricted to all cases of Kaposi sarcoma, irrespective of aetiology, including the classic, the HIV associated and the transplant related variants. HHV8 DNA was also detected in early lesions of Kaposi sarcoma. HHV8 DNA was not detected in other mesenchymal skin tumours nor in non-specific inflammatory skin lesions, even in the presence of active HIV infection.
Our findings supply further evidence of a possible aetiological role for HHV8 in the development of Kaposi sarcoma in conjunction with immunosuppression. Previous studies found HHV8 DNA in 36.3-89% of skin biopsy specimens adjacent to primary Kaposi sarcoma lesions.'2 1415 Whether this is indicative of diffuse spread of the virus or whether this is a presarcomatous lesion has yet to be determined. At least for patients with AIDS, the presence of HHV8 DNA without clinical evidence of overt Kaposis's sarcoma may identify those at risk of developing Kaposi sarcoma at a later stage of their disease. '6 In conclusion, our data show that HHV8 DNA can be detected by nested PCR in all biopsy specimens of Kaposi sarcoma but not in other mesenchymal tumours or non-specific inflammatory skin lesions. Given that the early vascular lesions of Kaposi sarcoma may be subtle and difficult to diagnose, the detection of HHV8 DNA by PCR will become a important tool to confirm the diagnosis of Kaposi sarcoma.
